Status | Study |
Not yet recruiting |
Study Name: Severe and Cerebral Malaria Investigated Through Host Metabolomics Condition: Severe Malaria Date: 2015-05-15 Interventions: Other: Observation |
Completed |
Study Name: A Safety and Feasibility Study of Enteral LVT vs. Standard of Care for Seizure Control in Pediatric CM Condition: Seizure Epilepsy Cerebral Malaria Date: 2013-11-05 Interventions: Drug: Oral Levetiracetam liqui |
Completed |
Study Name: Enteral Levetiracetam For Seizure Control In Pediatric Cerebral Malaria Condition: Seizure Epilepsy Cerebral Malaria Date: 2012-07-19 Interventions: Drug: LEVETIRACETAM liquid, 40 mg/kg loading dose and 30mg/kg every 12 hours via nasogastric tube for 3 |
Completed |
Study Name: Rapid Diagnostic Tests and Clinical/Laboratory Predictors of Tropical Diseases in Neurological Disorders in DRC Condition: Neurological Disorders Cerebral Malaria Date: 2012-04-26 Interventions: Device: Immunochromatographic HAT tests (DSD) |
Completed |
Study Name: Evaluation of the Efficacy and Safety of Inhaled Nitric Oxide as Adjunctive Treatment for Cerebral Malaria in Children Condition: Malaria, Cerebral Date: 2010-11-23 Interventions: Drug: inhaled nitric oxide Stu |
Completed |
Study Name: Randomized Trial of Erythropoietin During Cerebral Malaria Condition: Cerebral Malaria Date: 2008-06-11 Interventions: Drug: Placebo Saline Admission |
Completed |
Study Name: Rehabilitation Program for Cognitive Deficits in Ugandan Children After Cerebral Malaria Condition: Malaria, Cerebral Date: 2008-04-10 Interventions: Behavioral: Cognitive rehabilitation training A computeris |
Completed |
Study Name: Hyperphenylalaninemia in Cerebral Malaria Condition: Plasmodium Falciparum Malaria Date: 2006-06-15 |
Completed |
Study Name: Study of the Safety of Intravenous Artesunate Condition: Malaria Malaria, Cerebral Date: 2006-02-14 Interventions: Drug: Intravenous artesunate |
Terminated |
Study Name: Pentoxifylline in Children With Malaria Condition: Plasmodium Falciparum Malaria Date: 2005-08-19 Interventions: Drug: Pentoxifylline |